07.30.15
Marietta, Ga.-based Amendia Inc., which makes spine devices, has acquired the business of Custom Spine Inc. Since 2003, Parsippany, N.J.-based Custom Spine has developed an extensive portfolio of new generation, surgeon-friendly spinal technologies. Company officials said that the Custom Spine transaction is a new milestone for Amendia, ideally positioning the company for sustainable and scalable growth.
The business combination will further support Amendia’s focus on providing the spine market with a comprehensive product offering in a vertically-integrated business model, designed to maximize efficiencies, cost savings, customer service, and creativity.
This acquisition comes on the heels of Amendia’ purchase of certain assets of minimally invasive spine device company Tupelo, Miss.-based SpineSelect LLC.
“I’m looking forward to adding Custom Spine’s technologies to Amendia’s comprehensive product offering. Custom Spine’s rich IP portfolio, engineering know-how, skilled sales force, and customer base makes this transaction an easy fit for both companies,” said Jeff Smith, Amendia’s CEO. “Custom Spine brings the rights to 40 patents to Amendia, which instantaneously increases the breadth and depth of our research and development pipeline. This is very exciting for the company and also for patient care.”
The portfolio integration of “Pathway AVID,” one of Custom Spine’s signature technologies, is expected to have an immediate positive impact on Amendia’s distribution network. Pathway AVID (patent pending) is a unique articulating vertebral interbody device (AVID) that provides optimal structural support while enhancing spinal fusion. The device includes three intra-linked PEEK (polyethethertherketone) cages, which are inserted using a standard transforaminal approach. Once inside the disc space, each segment is sequentially articulated, providing better placement control with a large footprint to increase structural support.
“The business combination of Amendia and Custom Spine brings together two highly complementary companies,” said Mahmoud Abdelgany, Custom Spine’s CEO. “It creates an organization uniquely qualified to meet the needs of today’s ever-evolving healthcare market, to the benefit of patients, surgeons, distributors, hospitals, and payers.”
The business combination will further support Amendia’s focus on providing the spine market with a comprehensive product offering in a vertically-integrated business model, designed to maximize efficiencies, cost savings, customer service, and creativity.
This acquisition comes on the heels of Amendia’ purchase of certain assets of minimally invasive spine device company Tupelo, Miss.-based SpineSelect LLC.
“I’m looking forward to adding Custom Spine’s technologies to Amendia’s comprehensive product offering. Custom Spine’s rich IP portfolio, engineering know-how, skilled sales force, and customer base makes this transaction an easy fit for both companies,” said Jeff Smith, Amendia’s CEO. “Custom Spine brings the rights to 40 patents to Amendia, which instantaneously increases the breadth and depth of our research and development pipeline. This is very exciting for the company and also for patient care.”
The portfolio integration of “Pathway AVID,” one of Custom Spine’s signature technologies, is expected to have an immediate positive impact on Amendia’s distribution network. Pathway AVID (patent pending) is a unique articulating vertebral interbody device (AVID) that provides optimal structural support while enhancing spinal fusion. The device includes three intra-linked PEEK (polyethethertherketone) cages, which are inserted using a standard transforaminal approach. Once inside the disc space, each segment is sequentially articulated, providing better placement control with a large footprint to increase structural support.
“The business combination of Amendia and Custom Spine brings together two highly complementary companies,” said Mahmoud Abdelgany, Custom Spine’s CEO. “It creates an organization uniquely qualified to meet the needs of today’s ever-evolving healthcare market, to the benefit of patients, surgeons, distributors, hospitals, and payers.”